Home » Authors » Peter O'Donnell

Articles by Peter O'Donnell

European Union Ministers Duck GM Potato Decision

July 18, 2007

By Peter O'Donnell

EuropaBio Applauds Guidance On Treatment of Biosimilars

July 18, 2007

By Peter O'Donnell

EU Prediction: Europe's Biotech Future Will Depend On Change

July 11, 2007

By Peter O'Donnell

EU Prediction: Europe's Biotech Future Will Depend On Change

July 11, 2007

By Peter O'Donnell

European Scientists Back GMOs In Face Of Growing Opposition

July 4, 2007

By Peter O'Donnell

European Drug Chief Slams Pharmaceutical Talk-Shop

July 4, 2007

By Peter O'Donnell

European Drug Chief Slams Pharmaceutical Talk-Shop

July 4, 2007

By Peter O'Donnell

European Scientists Back GMOs In Face Of Growing Opposition

July 4, 2007

By Peter O'Donnell

European Biotech Industry Still Has Heavy Agenda

June 27, 2007

By Peter O'Donnell

European Biotech Industry Still Has Heavy Agenda

June 27, 2007

By Peter O'Donnell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...